Two Sigma Advisers’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.2M | Sell |
|
|||||
|
2025
Q1 | $16.1M | Sell |
|
|||||
|
2024
Q4 | $23.2M | Buy |
|
|||||
|
2024
Q3 | $7.45M | Buy |
|
|||||
|
2024
Q2 | $900K | Buy |
|
|||||
|
2024
Q1 | $407K | Sell |
|
|||||
|
2023
Q4 | $2.18M | Buy |
|
|||||
|
2023
Q3 | $390K | Sell |
|
|||||
|
2023
Q2 | $4.08M | Buy |
|
|||||
|
2023
Q1 | $231K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $234K | Sell |
|
|||||
|
2022
Q1 | $1.38M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $4.89M | Sell |
|
|||||
|
2020
Q4 | $22.6M | Sell |
|
|||||
|
2020
Q3 | $26.3M | Buy |
|
|||||
|
2020
Q2 | $19.4M | Buy |
|
|||||
|
2020
Q1 | $2.61M | Sell |
|
|||||
|
2019
Q4 | $4.48M | Sell |
|
|||||
|
2019
Q3 | $3.86M | Buy |
|
|||||
|
2019
Q2 | $1.91M | Sell |
|
|||||
|
2019
Q1 | $1.96M | Buy |
|
|||||
|
2018
Q4 | $881K | Buy |
|